4
Changes in Ownership
ProMIS Neurosciences Inc. Filed Acc 0001927064-25-000002
Options or other derivatives
- Chief Scientific Officer acquired 165,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Cashman Neil Chief Scientific Officer | 2025-09-22 | Grant or award · Option (right to buy) | +165,000 | 165,000 | D | ||
Loading xslF345X05/primary_doc.xml…